Victoza (liraglutide) – 3 ml (6mg/ml) – Novo Nordisk – expires 2031

Description

The price is for one pen, not for the entire box.

The medication comes as a liquid inside a prefilled injection pen. Victoza is an FDA-approved, prescription injectable medicine that, when used in conjunction with a low-calorie diet and increased exercise, may help some adults with excess weight who have weight-related medical problems lose weight and keep it off. It is for use in adults only. Victoza contains the active drug liraglutide. It belongs to a group of drugs called GLP-1 agonists.

Dosage:

Patients should follow a 4-week dose escalation to reach the clinically efficacious 3 mg dose. The 4-week dose-escalation period can reduce the likelihood of gastrointestinal symptoms. The Victoza® starting dose is 0.6 mg per day for 1 week.1 Patients increase the dose by 0.6 mg each week until the full maintenance dose of 3 mg is reached.

For information on how to use and inject please see these instructions:

https://www.victoza.com/

Side effects:

The most common side effect a patient may experience when they first start Victoza® is nausea. This usually improves as their body adjusts to treatment.